L Birinyi1, N Kalamász, A G Juhász, T Major, A Borsos, Gy Bacskó. 1. Department of Obstetrics and Gynecology, Medical and Health Science Center, University of Debrecen, Nagyerdei krt. 98, Debrecen H-4012, Hungary. fabian@jaguar.hu
Abstract
STUDY OBJECTIVE: To measure the efficacy of transcervical hysteroscopic fibroid resection (TCRM) among the authors' patients. STUDY DESIGN: In one department, 73 transcervical hysteroscopic fibroid resections were performed on 68 patients over a 6-year period. Using a computerized database and mailed questionnaires, 58 patients were followed up. RESULTS: Thirty-six of the 58 patients showed no symptoms after the procedure; in 15 cases subsequent fibroid was detected, while in seven cases other types of complaints occurred, not related to the myoma. During the procedures complications happened in four cases; one perforation and three bleeding episodes occurred. CONCLUSION: Our data indicate that TCRM is a safe and successful method of treating submucosal fibroids.
STUDY OBJECTIVE: To measure the efficacy of transcervical hysteroscopic fibroid resection (TCRM) among the authors' patients. STUDY DESIGN: In one department, 73 transcervical hysteroscopic fibroid resections were performed on 68 patients over a 6-year period. Using a computerized database and mailed questionnaires, 58 patients were followed up. RESULTS: Thirty-six of the 58 patients showed no symptoms after the procedure; in 15 cases subsequent fibroid was detected, while in seven cases other types of complaints occurred, not related to the myoma. During the procedures complications happened in four cases; one perforation and three bleeding episodes occurred. CONCLUSION: Our data indicate that TCRM is a safe and successful method of treating submucosal fibroids.